We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Ophthalmology

Ophthalmology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1
newscase reportdiagnosis

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1

By MedXY|Sep 13, 2026

A case series delineating a novel EFEMP1 variant, p.Arg140Trp, associated with late-onset peripheral retinal degeneration distinct from classic DHRD/ML, highlighting rod dysfunction precedes structural changes.

Why Metrics Matter in Thyroid Eye Disease: Exploring the Innovate TED Initiative
Diabetes & EndocrinologyClinical MetricsInnovate TED Initiative

Why Metrics Matter in Thyroid Eye Disease: Exploring the Innovate TED Initiative

By MedXY|Sep 13, 2026

This article examines the critical need for refined clinical metrics in thyroid eye disease (TED) to better evaluate new targeted therapies, highlighting the Innovate TED Initiative’s efforts to develop and validate comprehensive outcome me

Differential Impact of Reticular Pseudodrusen Subtypes on Retinal Sensitivity in Intermediate Age-Related Macular Degeneration
newsmicroperimetryretinal sensitivity

Differential Impact of Reticular Pseudodrusen Subtypes on Retinal Sensitivity in Intermediate Age-Related Macular Degeneration

By MedXY|Sep 12, 2026

This study elucidates how ribbon-type reticular pseudodrusen, especially when coexisting with soft drusen, significantly impair retinal sensitivity in intermediate AMD, highlighting the importance of lesion phenotype in functional risk asse

Unveiling Dupilumab-Associated Ocular Surface Disease in Atopic Dermatitis: Insights from a Large Prospective BioDay Cohort
Dermatologyatopic dermatitisdupilumab

Unveiling Dupilumab-Associated Ocular Surface Disease in Atopic Dermatitis: Insights from a Large Prospective BioDay Cohort

By MedXY|Sep 12, 2026

This study reveals that 30.7% of atopic dermatitis patients treated with dupilumab develop ocular surface disease, despite prevalent ocular symptoms at baseline and increased ophthalmic treatment during therapy, linked to reduced conjunctiv

Satralizumab Demonstrates Promising Efficacy and Safety in Treating Thyroid Eye Disease: Insights from Phase 3 SatraGO-1 and SatraGO-2 Trials
Diabetes & EndocrinologyThyroid Eye DiseaseSatralizumab

Satralizumab Demonstrates Promising Efficacy and Safety in Treating Thyroid Eye Disease: Insights from Phase 3 SatraGO-1 and SatraGO-2 Trials

By MedXY|Sep 12, 2026

Phase 3 trials show satralizumab significantly improves proptosis, inflammation, and diplopia in thyroid eye disease with a favorable safety profile, marking a new therapeutic option targeting the IL-6 receptor pathway.

Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity
Diabetes & Endocrinologyreal‑world evidencehealth disparities

Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity

By MedXY|Sep 11, 2026

A significant proportion of real-world diabetic macular edema patients are excluded from clinical trials of anti-VEGF therapy due to stringent systemic criteria, disproportionately affecting racial minorities. This study highlights the need

Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses
Clinical Updatesepidemiologykeratoconus

Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses

By MedXY|Sep 9, 2026

This review synthesizes evidence linking cumulative atopic diseases—including asthma, atopic dermatitis, and allergic rhinitis—to keratoconus risk, highlighting a dose-dependent association and the role of healthcare utilization in case asc

Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study
Diabetes & Endocrinologydry eye diseaseSex Differences

Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study

By MedXY|Sep 9, 2026

Central obesity in women and high overall body fat in men are linked to increased odds of dry eye disease, with distinct metabolic pathways implicated, based on a retrospective analysis of over 480,000 UK Biobank participants.

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics
Clinical Updatesvisual fieldglaucoma

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics

By MedXY|Sep 9, 2026

This review synthesizes recent evidence on event-based progression detection in glaucoma, highlighting that OCTA vessel density may identify progression earlier than structural OCT or visual field testing, with important implications for cl

Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance
Clinical UpdatesMRIhigh myopia

Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance

By MedXY|Sep 9, 2026

This review synthesizes longitudinal evidence on 3D eye shape remodeling in high myopia, linking distinct morphologic trajectories to sight-threatening outcomes and supporting individualized risk stratification beyond axial length alone.

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial
Clinical Updatesrandomized clinical trialStargardt disease

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial

By MedXY|Sep 7, 2026

This review synthesizes evidence from the TEASE-1 trial and related studies on gildeuretinol acetate, highlighting its safety profile and modest efficacy in slowing retinal atrophic lesion growth in Stargardt disease over 24 months.

Prevalence and Characteristics of Null Studies in Ophthalmology: A Comprehensive Analysis from 2014 to 2025
newsophthalmology researchpublication bias

Prevalence and Characteristics of Null Studies in Ophthalmology: A Comprehensive Analysis from 2014 to 2025

By MedXY|Sep 5, 2026

A large-scale PubMed analysis reveals that one in five ophthalmology studies report null primary outcomes, with declining prevalence over time and notable differences in funding, design, and journal impact between null and positive studies.

Impact of Neighborhood Socioeconomic Deprivation on Diabetic Retinopathy Screening Adherence in Medicare Beneficiaries
Diabetes & EndocrinologyArea Deprivation Indexretinopathy đái tháo đường

Impact of Neighborhood Socioeconomic Deprivation on Diabetic Retinopathy Screening Adherence in Medicare Beneficiaries

By MedXY|Sep 1, 2026

Increasing neighborhood socioeconomic deprivation is associated with reduced adherence to annual diabetic retinopathy screening among Medicare patients, highlighting disparities in preventive eye care.

Long-Term Incidence and Risk Factors for Glaucoma: Insights from the Gangnam Eye Cohort Study
newscohort studyglaucoma

Long-Term Incidence and Risk Factors for Glaucoma: Insights from the Gangnam Eye Cohort Study

By MedXY|Aug 31, 2026

A 10-year Korean cohort study reveals that retinal arteriosclerosis, intraocular pressure, age, serum uric acid, and cholesterol levels significantly increase the risk of structural glaucoma conversion.

Digital Defocus Vision Training Using Virtual Reality for Myopia Control: Current Evidence and Clinical Implications
Clinical Updatesmyopia controldigital defocus vision training

Digital Defocus Vision Training Using Virtual Reality for Myopia Control: Current Evidence and Clinical Implications

By MedXY|Aug 31, 2026

Virtual reality-based digital defocus vision training (DDVT) shows promise as a home-based adjunct to slow myopia progression in children, with randomized trial data demonstrating modest reductions in axial length and refractive error progr

Evaluating HOTV Versus Tumbling E Vision Tests for Effective Pediatric Screening
newsPediatric Vision Screeningamblyopia detection

Evaluating HOTV Versus Tumbling E Vision Tests for Effective Pediatric Screening

By MedXY|Aug 31, 2026

This study compares HOTV and tumbling E vision tests in children aged 3 to 15, demonstrating HOTV’s superior accuracy and suitability for children under 8, potentially reducing unnecessary referrals in pediatric vision screening.

Beyond Vision Loss: Psychosocial Factors Influencing Psychological Distress in Primary Open-Angle Glaucoma
newsprimary open-angle glaucomapsychological distress

Beyond Vision Loss: Psychosocial Factors Influencing Psychological Distress in Primary Open-Angle Glaucoma

By MedXY|Aug 31, 2026

This study reveals psychosocial factors such as social support and self-efficacy significantly influence psychological distress in primary open-angle glaucoma, beyond clinical disease measures.

IOP Stress Testing Identifies Glaucoma Eyes at Risk of Fast Progression Despite Controlled Office Pressure
newsvisual fieldIOP stress test

IOP Stress Testing Identifies Glaucoma Eyes at Risk of Fast Progression Despite Controlled Office Pressure

By MedXY|Aug 28, 2026

A stress test measuring intraocular pressure identifies glaucoma patients at risk of rapid progression despite normal office pressure readings, offering complementary prognostic insights beyond routine checks.

Intraday Upper Blepharoplasty Closure: Comparing Intradermal and Continuous Sutures for Optimal Outcomes
newsintradermal suturesscar aesthetics

Intraday Upper Blepharoplasty Closure: Comparing Intradermal and Continuous Sutures for Optimal Outcomes

By MedXY|Aug 27, 2026

This paired-eye randomized study evaluates the aesthetic results of intradermal versus continuous external sutures in upper blepharoplasty, revealing similar long-term scar quality and high patient satisfaction.

Long-Term Efficacy and Visual Field Outcomes of Selective Laser Trabeculoplasty in Glaucoma Management
newsvisual field progressionglaucoma

Long-Term Efficacy and Visual Field Outcomes of Selective Laser Trabeculoplasty in Glaucoma Management

By MedXY|Aug 26, 2026

This study evaluates long-term outcomes of selective laser trabeculoplasty (SLT) in controlling intraocular pressure and preventing visual field deterioration, identifying clinical factors influencing effectiveness and progression risk.

Prev
2 / 12
1234…12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles